Asked by: Lord Carlile of Berriew (Crossbench - Life peer)
Question to the Home Office:
To ask His Majesty's Government how they will maintain routes for international students to study and work in the UK.
Answered by Lord Sharpe of Epsom - Parliamentary Under-Secretary (Home Office)
The student route launched in 2020 and provides a way for international students to apply to study in the UK. Some students have work rights such as those studying at degree level and above at higher education institutions, who can work for up to 20 hours per week during term-time, and full-time during vacations. Upon course completion, students may apply to extend their leave in the UK, including under work routes, if relevant requirements are met.
We keep all our immigration policies under constant review to ensure they best serve the UK and reflect the public’s priorities.
Asked by: Lord Carlile of Berriew (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to mitigate the current shortage of the psychotropic medication Olanzapine, Risperidone and Haloperidol following the sudden departure of two generic manufacturers from the UK market.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
We are aware that there have been supply constraints with olanzapine 210 milligram, 300 milligram, and 405 milligram powder and solvent for prolonged release suspension for injection. We worked with manufacturers to uplift production, and the issues were resolved in February 2024. We worked with NHS England to issue national communications containing advice on how to manage patients whilst there was a disruption to supply. We are not aware of any supply issues affecting oral presentations of olanzapine, or of any supply issues with any risperidone or haloperidol products.
Asked by: Lord Carlile of Berriew (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the impact of the shortage of the psychotropic medication Olanzapine, and what steps they are taking to ensure that such shortages do not affect the health and safety of patients, and wider public safety.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
We are aware that there have been supply constraints with olanzapine 210 milligram, 300 milligram, and 405 milligram powder and solvent for prolonged release suspension for injection. We worked with manufacturers to uplift production, and the issues were resolved in February 2024. We worked with NHS England to issue national communications containing advice on how to manage patients whilst there was a disruption to supply. We are not aware of any supply issues affecting oral presentations of olanzapine, or of any supply issues with any risperidone or haloperidol products.